NFKB1 and non-small cell lung carcinoma: In a recent in vitro study by Wang et al., BAY11-7082, a NF-κB pathway suppressor, inhibited EMT and cancer cell stemness in hypoxic conditions in the SPC-A1 and H1299 NSCLC cell lines.